Medipharm Labs

Medipharm Labs EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Medipharm Labs (LABS.TO) as of Nov 3, 2026 is -8.41 M CAD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -10.38 M CAD — a change of -18.98% (higher).

EBITDA

-8.41 MCAD

YoY

-18.98%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Medipharm Labs is 2025 -8.41 M CAD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Medipharm Labs was 2024 -10.38 M CAD. It decreases by -18.98% higher compared to the previous year.

The Medipharm Labs EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
386,462.00 CAD
Jan 1, 2019
7.94 M CAD
Jan 1, 2020
-70.68 M CAD
Jan 1, 2021
-43.01 M CAD
Jan 1, 2022
-28.73 M CAD
Jan 1, 2023
-17.80 M CAD
Jan 1, 2024
-10.38 M CAD
Jan 1, 2025
-8.41 M CAD
The Medipharm Labs EBITDA history
YEAREBITDAYoY
-8.41 MCAD-18.98%
-10.38 MCAD-41.69%
-17.80 MCAD-38.05%
-28.73 MCAD-33.19%
-43.01 MCAD-39.15%
-70.68 MCAD-990.35%
7.94 MCAD+1,954.02%
386,462.00CAD-140.77%
-948,000.00CAD+607.80%
-133,936.00CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Medipharm Labs Stock analysis

What does Medipharm Labs do? MediPharm Labs Corp is a leading company in the cannabis industry, specializing in the production of specialized, high-quality cannabis products. The company was founded in 2015 by founders Pat McCutcheon and Keith Strachan and is headquartered in Barrie, Ontario, Canada. Medipharm Labs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medipharm Labs stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Medipharm Labs is -8.41 M CAD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Medipharm Labs changed from -10.38 M CAD to -8.41 M CAD, representing a -18.98% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Medipharm Labs since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Medipharm Labs historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Medipharm Labs

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Medipharm Labs